OvaScience, Intrexon Collaborate on OvaScience's OvaTure Technology for Infertility Treatments

OvaScience, OVAS and Intrexon Corporation XON today announced an agreement to access Intrexon's portfolio of technologies to accelerate the development of OvaScience's OvaTure℠ technology platform. Separately, the companies established a Joint Venture, called OvaXon, to combine their unique technology platforms to create new applications for improving human and animal health. See full press release